RE: Vulpes share investments in Scancell.28 Apr 2020 13:15
'And it's nothing to do with the main Vulpes investment either?'
Maybe you should read the RNS - there is a reason it states:
'Following the sale, Vulpes Life Science Fund holds 78,549,311 ordinary shares representing 16.9% of the company.'
The reason is that the 'main Vulpes investment' has been partially sold off.